FACULTY

John W. Devlin, PharmD, BCPS, FCCM, FCCP
Associate Professor
Northeastern University School of Pharmacy
Clinical Pharmacist, Medical ICU
Tufts Medical Center
Boston, Massachusetts

FINANCIAL DISCLOSURES

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME/CE activity:

• John W. Devlin, PharmD, BCPS, FCCM, FCCP, has received grant/research support from and served as a consultant for Hospira.

ACCREDITATION STATEMENT

Pharmacy
The France Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and will award 0.075 CEU to pharmacists who attend the activity and complete the registration and evaluation forms. There is no fee to participate in this activity. This is an application-based activity. Statements of credit will be issued immediately.
UAN: 0391-0000-11-007-H01-P

TYPE OF ACTIVITY: Application

TECHNICAL REQUIREMENTS: Adobe Presenter

Published: June 22, 2011          Expires: June 21, 2012

Media: Webcast

Estimated time to complete activity: Estimated time to complete this activity is 45 minutes.

PROCEDURE

Method of Participation / How to Receive Credit:

1. Review the activity objectives and CE information.
2. Complete the CE activity.
3. Complete the posttest. A score of at least 70% is required to successfully complete this activity.
4. Complete the CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
5. Your CE certificate will be available for download after you submit the completed evaluation form.

TARGET AUDIENCE

This activity is intended for anesthesiologists, surgeons, pulmonologists, intensivists, CRNAs, ICU, CCU, SICU nurses, and hospital pharmacists who manage patients requiring sedation in intensive care and perioperative settings.

STATEMENT OF NEED

Patients in intensive care or undergoing procedures frequently require pain management. Assessment of pain, sedation, agitation, and delirium with validated scales is a critical part of maintaining the balance between oversedation and undersedation. Practical application of recent results from patient management trials and from pharmaceutical clinical trials can enhance the practice of sedation and patient outcomes.

EDUCATIONAL OBJECTIVE

Upon completion of this activity, the participants should be able to:

• Assess recent clinical findings in sedation and analgesia management and incorporate them into the management of patients in the acute care, procedural, and surgical sedation settings

Disclosure
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures
The planners, reviewers, editors, staff, CME/CE committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures
The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME/CE activity:

• John W. Devlin, PharmD, BCPS, FCCM, FCCP, has received grant/research support from and served as a consultant for Hospira.

Unapproved Use Disclosure
The France Foundation requires CME/CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

DISCLAIMER

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and Hospira assume no liability for the information herein.

COPYRIGHT INFORMATION
Copyright © 2011 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.